Actively Recruiting
IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-01-15
540
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
I
INSERM U942
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational physiopathological study aimed at evaluating the immunological and inflammatory determinants associated with the prognosis of patients admitted to intensive care units (ICU). The study will establish multidimensional models predicting one-year survival and the occurrence of nosocomial infections. Patients admitted to ICU undergo routine biological sampling. In addition to these, minimal supplementary samples will be collected for immunological and inflammatory biomarker analysis at admission, day 1, day 4, day 8, ICU discharge or day 28, and at 12 months. Additional samples may be taken during clinically significant events (nosocomial infections, complications).
CONDITIONS
Official Title
IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Admission to ICU within 24 hours
You will not qualify if you...
- Moribund patient (ECOG=4)
- Under legal protection (guardianship or curatorship)
- Uninsured patients
- Pre-existing immunosuppression (active/recent cancer, hematologic disease, autoimmune disease, organ transplant, HIV)
- Pregnant or breastfeeding women
- Participation in another interventional trial
- Patients under AME
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AP-HP Laribosière Hospital, Anesthesia and Critical Care Departement
Paris, France, 75010
Actively Recruiting
Research Team
C
Charles de de Roquetaillade, MD
CONTACT
B
Benjamin Glenn Chousterman, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here